Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 78 out of 100. Disparities

Topic: Risk, prevention and care in population studies

Plain-language summary

Importance Dual decline in gait speed and cognition has been found to be associated with increased dementia risk in previous studies. Results Of 19 114 randomized participants, 16 855 (88.2%) had longitudinal gait and cognitive data for inclusion in this study (mean [SD] age, 75.0 [4.4] years; 9435 women [56.0%], 7558 participants [44.8%] with 12 or more years of education). Compared with nondecliners, risk of dementia was highest in the gait plus HVLT-R decliners (hazard ratio [HR], 24.7; 95% CI, 16.3-37.3), followed by the gait plus 3MS (HR, 22.2; 95% CI, 15.0-32.9), gait plus COWAT-F (HR, 4.7; 95% CI, 3.5-6.3), and gait plus SDMT (HR, 4.3; 95% CI, 3.2-5.8) groups. Dual decliners had a higher risk of dementia than those with either gait or cognitive decline alone for 3MS and HVLT-R. These findings support the inclusion of gait speed in dementia risk screening assessments.

What this study adds

Evidence grade: High

This is a follow-up (cohort) study of 7,558 participants. Older adults who declined in both gait speed and cognition had a much higher risk of later dementia than those who did not decline. Reported effect size: 88.2%; 56.0%; 44.8%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Collyer, T. A., Murray, A. M., Woods, R. L., Storey, E., Chong, T. T., Ryan, J., et al. (2022). Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2022.14647

Vancouver

Collyer TA, Murray AM, Woods RL, Storey E, Chong TT, Ryan J, et al. Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults. JAMA network open. 2022. doi:10.1001/jamanetworkopen.2022.14647. PMID: 35639376.

BibTeX

@article{collyer2022-35639376,
  author  = {Collyer, T. A. and Murray, A. M. and Woods, R. L. and Storey, E. and Chong, T. T. and Ryan, J. and Orchard, S. G. and Brodtmann, A. and others},
  title   = {{Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults}},
  journal = {JAMA network open},
  year    = {2022},
  doi     = {10.1001/jamanetworkopen.2022.14647},
  pmid    = {35639376},
  url     = {https://doi.org/10.1001/jamanetworkopen.2022.14647}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

Older adults who declined in both gait speed and cognition had a much higher risk of later dementia than those who did not decline. The authors say gait speed should be included in dementia risk screening, but this is about predicting risk, not treating, curing, or preventing dementia.

Study details

How this study scored 78/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 2 of 4; Study design 11 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 3 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomized / blinded 1 of 2; Times cited 5 of 7; Citations per year 4 of 5; Impact for its field and year 4 of 6; Cited by studies here 2 of 6; Still being cited 3 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multicenter collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 78 of 100.78 of 100 points earned22 not earned

Published in a leading specialty journal, and it is a randomized controlled trial.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (JAMA network open)
Journal's citation record 2 / 4 JAMA Network Open: journal h-index 235 (OpenAlex, 2026-10-29)
Study design 11 / 12 A randomized controlled trial (from PubMed type “Randomized Controlled Trial”)
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2022 — within 6 year(s) of the newest study here
Sample size 3 / 4 7,558 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 1 / 2 Randomized (as stated in the record)
Times cited 5 / 7 Cited 135 times (OpenAlex, 2026-10-10)
Citations per year 4 / 5 22.5 citations a year over 6 year(s) since 2022
Impact for its field and year 4 / 6 Cited 15.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 2 / 6 Cited by 4 other studies in this library
Still being cited 3 / 4 Cited 110 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Michele L. Callisaya: h-index 47 (OpenAlex, whole career)
Institution's track record 2 / 3 University of Minnesota: institution h-index 1,568 (OpenAlex)
Multicenter collaboration 3 / 3 OpenAlex lists 10 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 35639376)
Free to read 2 / 2 Free to read
Total 78 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.

Later studies that cite this one

4 studies in the alzhub library list this one in their references.

Related studies in Disparities from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Disparities

See all studies in Disparities →